Launch Your Global Biotherapeutics Career — Henlius Early Development Trainee Program Is Now Open! → Are you a PhD scientist (2026) passionate about turning biological insight into first-in-class biologics? 🌍Henlius — a leading oncology treatments in antibody therapeutics and AI-integrated drug development, a global, innovation-driven biopharmaceutical company committed to delivering high-quality, affordable biologic therapies to patients worldwide. — is recruiting exceptional early-career scientists for its flagship Early Development Trainee Program. 🔹 Why apply? → Rotate across real, clinical-stage projects: Antibody Discovery • AIDD • Biology & Pharmacology • Preclinical PK/PD → Co-mentored by CSO-level scientists + R&D Function Head → Fast-track to full-time Scientist roles at Henlius’ R&D hubs